Current treatment of organophosphorus poisoning, resulting in overstimulation and desensitization of muscarinic and nicotinic receptors by acetylcholine (ACh), consists of the administration of atropine and oxime reactivators. However, no versatile oxime reactivator has been developed yet and some mortality still remains after application of standard atropine treatment, probably due to its lack of antinicotinic action. In our study, we focused on the interesting non-acetylcholinesterase property of oximes, i.e. antinicotinic effect of reactivators. Two standard reactivators (HI-6, obidoxime) and two new compounds (K027 and K203) were chosen and in vitro (patch clamp) and in vivo (nerve-evoked muscle contraction) testings were applied. Both examinations showed antinicotinic effects of the reactivators. In vitro inhibition of acetylcholine-evoked currents by obidoxime, HI-6 and K203 was equivalent while K027 was less potent. Similar order of potency was observed by the in vivo examiations. We thus confirm previous in vitro results, which describe antinicotinic effects of oxime reactivators, and furthermore, we show in vivo antagonism of oxime reactivators exerted by inhibition of the ACh effect on the nicotinic receptor in the neuromuscular junction. Taking together, the effects of tested oxime reactivators indicate an antagonism on both embryonic and adult form of the nicotinic receptors.
Summary:
Current treatment of organophosphorus poisoning, resulting in overstimulation and desensitization of muscarinic and nicotinic receptors by acetylcholine (ACh), consists of the administration of atropine and oxime reactivators. However, no versatile oxime reactivator has been developed yet and some mortality still remains after application of standard atropine treatment, probably due to its lack of antinicotinic action. In our study, we focused on the interesting non-acetylcholinesterase property of oximes, i.e. antinicotinic effect of reactivators. Two standard reactivators (HI-6, obidoxime) and two new compounds (K027 and K203) were chosen and in vitro (patch clamp) and in vivo (nerve-evoked muscle contraction) testings were applied. Both examinations showed antinicotinic effects of the reactivators. In vitro inhibition of acetylcholine-evoked currents by obidoxime, HI-6 and K203 was equivalent while K027 was less potent. Similar order of potency was observed by the in vivo examiations. We thus confirm previous in vitro results, which describe antinicotinic effects of oxime reactivators, and furthermore, we show in vivo antagonism of oxime reactivators exerted by inhibition of the ACh effect on the nicotinic receptor in the neuromuscular junction. Taking together, the effects of tested oxime reactivators indicate an antagonism on both embryonic and adult form of the nicotinic receptors. However, 20% mortality still remains after application of standard atropine treatment (Eddleston et al. 2008 ). An explanation to this persisting mortality could be the lack of in vivo nicotinic antagonism of the compound (Tobin et al. 1991; Luo et al. 2010 ).
HI-6 and obidoxime are the most commonly used oxime reactivators in the treatment of organophosphorus poisoning. HI-6, a broad-spectrum antidote, is considered to be the most effective and is effective against soman, sarin and VX (Kassa 2002), but it is less effective against tabun (Puu et al. 1986 ). On the other hand, obidoxime is used in the treatment of both poisoning by tabun as well as by pesticides (Kassa 2002 Such an alternative approach presumes other mechanisms of oximes, not related to the reactivation (Hamilton and Lundy 1989; Vanhelden et al. 1992; Tattersall 1993; van Helden et al. 1996; Soukup et al. 2010a) . Oximes have been reported to act at several levels of the cholinergic transmission including synthesis, release, inactivation and re-uptake of the transmitter, but the interaction with cholinoreceptors has been put forward as the most plausible alternative of mechanism of action (Tattersall 1993; van Helden et al. 1996) . Both standard reactivators, obidoxime (Soukup et al. 2010b ) and HI-6, (Hamilton and Lundy 1989; Soukup et al. 2008) have been reported to exert some antimuscarinic properties. Antinicotinic action, which atropine lacks and which can prevent respiratory failure, has also been reported.
Both neuromuscular blocking (Schlagmann et al. 1990; Tattersall 1993; Chiou and Chang 1994) and ganglioblocking (Lundy and Tremblay 1979; Schlagmann et al. 1990 ) types of antinicotinic action have been reported. However, the reported in vitro properties do not correlate with the antidotal observations in vivo.
In our study, we have chosen two standard reactivators (HI-6, obidoxime) and two newly synthesized promising compounds (K027 and K203) in order to investigate their antinicotinic properties (for structure see Fig. 1 ). K027 may become the preferred antidote in the treatment of poisoning by pesticides (Petroianu et al. 2007 ) and K203 is an effective compound in cases of inhibited AChE by tabun (Kovarik et al. 2009 ). We examined the differences in antinicotinic efficacy of the individual reactivators in vitro, and further, we wondered if the in vitro findings had any in vivo significance. Male rats of the Sprague-Dawley strain (200-300 g) were anaesthetized with pentobarbitone (45 mg/kg, IP) and ketamine (50 mg/kg, IM) followed by supplementary doses injected intravenously as required during the experiments. Nerve-evoked maximal twitches of the tibialis anterior muscle of the right lower limb of the rat was monitored as described previously (Tran et al. 1982) . The free tendon of the tibialis anterior muscle was attached to a force transducer (Biopac, Goleta, USA) by a thread, while the right lower limb was kept immobilized. The resting tension of the muscle was adjusted to approximately 20-30 mN. A 3 cm incision was made from the gluteal region to the middle of the thigh. The muscle was carefully dissected to expose 2.0-2.5 cm of the sciatic nerve. The sciatic nerve was stimulated (1 Hz or 5 Hz for 10 s every 60 s, 4 V, 0.8 ms) with an electrode connected to a stimulator (Grass stimulator S88, Grass technologies, USA) to produce maximal twitches of the tibialis anterior muscle. Twitches were recorded in the presence and in the absence of a oxime reactivator. Reactivators were administered in a cumulative manner, I. V. (femoral vein) in four doses (10 µg, 100 µg, 1 mg and 10 mg per kg) and the stimulation (recording) was performed after 60 s from administration by stimulation frequencies at 1 Hz and 5 Hz applied for 10 s. The recording was done in duplicate, 60 s after the previous recording. The isometric twitches or tetanic tensions were continuously recorded. Data were recorded by MP100WSW data acquisition system and ACQKnowledge software (Biopac, Goleta, USA).
In vitro measurement of direct nicotinic receptor inhibition by the patch-clamp technique
The direct inhibitory effects of compounds were measured as the diminution of cationic current responses induced by 10 M acetylcholine on the nicotinic receptors. The ability of reactivators to inhibit ACh responses was then quantified.
The experiments were performed on TE671 cell line, which is medulloblastoma cell line endogenously expressing human embryonic muscle-like acetylcholine receptor (Schoepfer et al. 1988) . Even though the cell line is of neuronal origin, rhabdomyosarcoma properties has been described too (Stratton et al. 1989) . The whole-cell mode of patch-clamp method using an Axopatch 200A amplifier (Axon Instruments, Foster City, CA, USA) was applied. TE671 cells (kindly provided by Dr. Jan Ricny) were cultivated at 37 °C under 5% CO 2 atmosphere in a minimal essential medium (D-MEM), which was supplemented with 10 % of fetal calf serum (Dr. Kysilka, Brno). Nicotine (100 M) was added to cultivation medium 2-3 days before measurement to increase nAChRs expression (Ke et al. 1998) . Data were low-pass filtered at 1 kHz and digitized at 2 kHz. Cells were held at -40 mV during recordings.
Ionic current was induced by application of 10 M ACh for 5 s. The solution of inhibitor was applied as 10 s preapplication followed by the application together with 10 M ACh.
Data analysis
All data values are expressed as mean ± S.E.M. Statistical significance of in vivo experiment was determined by one-way analysis of variance (ANOVA) followed by the Dunnet´s multiple-comparison test. All statistical analyses were performed on raw data, but the graphs are presented in percentage. P-values less than 0.05 were regarded as statistically significant. Graphs were generated by using the GraphPad Prism software (GraphPad Software, Inc., San Diego, USA).. 
1. In vivo measurement of neuromuscular block
The basal amplitude of muscle twitches was 512±25 mN (n=20) at 1 Hz and 902±88 mN (n=19) at 5 Hz stimulation; an illustrative typical muscle twitches recording is shown (Fig.Fig. 3 ). The lowest dose of reactivators (10 µg/kg I.V.) caused reductions by 28±5%, 32±4%, 21±6%, 30±6% at 1 Hz (n=5, p<0.05) and only 16±2%, 15±8%, 7±2%, 10±2% at 5 Hz in obidoxime groups, HI-6, K027 and K203, respectively (n=5). The largest dose administered (10 mg/kg I.V.) caused at 1 Hz even larger reductions, namely 46±6%, 51±8%, 42±4%, 49±5% (n=5, p<0.05) for the same groups. On the other hand, at 5 Hz, no such clear progress occurred (37±3%, 46±12%, 32±5%, 13±5%) in the same groups (n=5). The inhibition, if any, was less; statistical significance was attained only at 1 Hz (Fig. 2) . (Fig. 4) . The comparison of reactivators´ inhibitory activity at the concentration of 200 M is summarized in Table 1 . 
Discussion
The principal mechanism of action of oxime antidotes is the reactivation of inhibited AChE. But still, the pharmacological effect of oximes is an open question. Doubtlessness, oximes affect the cholinergic transmission at several levels, and antimuscarinic and antinicotinic effects are two such sites (van Helden et al. 1996) . Today, atropine is frequently used in order to reduce effects connected with excessive ACh stimulation during the OP poisoning. ACh is the transmitter both at the ganglionic level in the autonomic nervous system and at the skeletal neuromuscular junction, and a blockade caused by atropine in the therapeutical doses is not sufficient to hinder all ACh effects (Tobin et al. 1991; Luo et al. 2010 ). On the other hand, atropine-induced shortening of the endplate postsynaptic potentials has been reported in the frog neuromuscular junction (Beranek and Vyskocil 1967) .
Previously, oximes have been shown to inhibit the nicotinic ion channel at the mouse muscle endplate and at the guinea-pig diaphragm preparations (Tattersall 1993) . Furthermore, ganglioblocking properties has been suggested too (Lundy and Tremblay 1979; Kirsch and Weger 1981) . However, contradictory observations exist and HI-6 and pralidoxime have been reported to also increase the opening probability of nicotinic receptors that are activated by ACh (Alkondon et al. 1988) . It has also been shown that all cholinesterase inhibitors, in addition to their well-known anti-AChE activity, have multiple effects on the nicotinic ACh receptor-ion channel macromolecule. The effects on the nicotinic ACh receptor have been reported to be exerted by competitive antagonism and by different types of noncompetitive blockade (van Helden et al. 1996) . In this context, it may be worth noting that binding and functional studies of the antagonism on muscarinic receptors have indicated a complexity in the mechanisms of action of oxime reactivators, which may be valid for the nicotinic antagonism as well (Amitai et al. 1980) . Two elements for ligands are necessary to interact with nAChR in the orthosteric site: H-bond acceptor group and positively charged nitrogen (Romanelli and Gualtieri 2003) . Both requirements are fulfilled by our oxime reactivators.
However, only small changes in the chemical structure may shift activity from agonist to antagonist. On the other hand, allosteric modulators belong to structurally very heterogenous group. Furthermore, the dose employed may differentiate between opposite effects (Romanelli and Gualtieri 2003) . From our observations, it is hard to deduce oximes´ mechanism of inhibition; more mechanistically focused experiments should be performed.
In the present study, nicotinolytic effects were shown to occur in vivo when studied on a tibial muscle preparation. This confirms previous in vitro observations (Tattersall 1993) . Taking experimental data together, oxime reactivators show an antagonism on both embryonic and adult form of the nicotinic receptors.
Furthermore, when the oxime effects were studied on the nicotinic channel in the TE671 cell line, inhibitory effects were also observed. In vivo, a difference between 1 Hz and 5 Hz stimulation was obvious. At 5 Hz stimulation, smaller inhibitory effects appeared, probably due to a larger availability of ACh at this frequency. Even though no statistical significance was shown, still dose-dependent effects seem to occur. It should be stressed that spontaneous fading of twitches may occur during a repetitive stimulation, probably due to changed sensitivity of the perceptual receptors (Van der Kloot et al. 1994 ). However, a decrease by 23% was reported after delivery of 3000 stimuli. In our study, only about 1000 stimuli were delivered and the reduction observed was up to 50%. Concerning individual compounds only small differences in potency appeared. If any difference in potency occurred between the various oximes, it was somewhat less for K027. However, the same pattern occurred when examined in the TE671 cell line. The compounds examined are hydrophilic. Therefore, it may be assumed that they mainly distribute into the water compartment. 
